Dr. Bob Hariri is an accomplished surgeon, biomedical scientist, high performance aviator and serial entrepreneur in two technology sectors, biomedicine and aerospace. He is the chairman, founder, and chief executive officer of Celularity, Inc., one of the world’s leading human cellular therapeutics companies. Dr. Hariri was the founder and CEO of Anthrogenesis Corporation, and after its acquisition by Celgene Corporation, served as CEO of Celgene Cellular Therapeutics. Dr. Hariri also co-founded the genomic-based health intelligence company, Human Longevity, Inc.
Dr. Hariri pioneered the use of stem cells to treat a range of life-threatening human diseases, and continues today to make transformative contributions in the fields of immuno-oncology and cell therapeutics along with tissue engineering and functional regeneration. He is widely acknowledged for his discovery of pluripotent stem cells and novel immune cells derived from the human placenta, and is a member of the team that discovered the physiological activities of tumor necrosis factor (TNF). He holds over 170 issued and pending patents for discoveries, including placenta-derived stem cells, which Nature recognized as one of the ten most important patent estates in the field. He has authored over 200 published chapters, articles, and abstracts.
Dr. Hariri twice received the Thomas Alva Edison Award for technological innovation, in 2007 and 2011, and is a recipient of the Children’s Brain Tumor Foundation’s Fred J. Epstein Lifetime Achievement Award. Dr. Hariri was awarded the 2018 Pontifical Key Innovation Award by Pope Francis. Over the years, he has received numerous honors for his many contributions to the fields of biomedicine and aviation.
Dr. Hariri is an adjunct associate professor of pathology at the Icahn School of Medicine at Mount Sinai. He is a former member of the board of visitors of the Columbia University School of Engineering and Applied Sciences, and the Science and Technology Council of the College of Physicians and Surgeons. He is a member of the XPRIZE Foundation scientific advisory board for the Archon XPRIZE for Genomics. Dr. Hariri is a trustee and vice-chair of the Liberty Science Center. In 2010 he was appointed as Commissioner of Cancer Research by New Jersey Governor, Chris Christie. Dr. Hariri serves on numerous public company and private foundation boards.
Dr. Hariri completed his undergraduate training at Columbia University School of Engineering and Applied Sciences and Columbia College. He received his M.D. and Ph.D. degrees from Cornell University, where he was the recipient of both the Julian R. Rachele Prize and the Doctoral Dissertation Award. He received his surgical and neurosurgical training at The New York Hospital-Cornell Medical Center where he specialized in traumatic brain injury. Dr. Hariri is a member of the Association of Military Surgeons and an expert in battlefield medicine.
When he is not in the laboratory or the corporate boardroom, Dr. Hariri is a jet-rated commercial pilot with thousands of hours of flight time in over 60 different military and civilian aircraft. He has also produced several feature films, as well as documentaries on global societal issues.